Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology

Demirci, Umut; Oflazoglu, Utku; Kodaz, Hilmi; Ciltas, Aydin; Kefeli, Umut; Akyol, Murat; Ozturk, Banu; Geredell, Caglayan; Seker, Mehmet Metin; Clhan, Saner; Tastekin, Dldem; Sevinc, Alper; Akinci, Muhammad Bulent; Taskoylu, Burcu Yapar; Duran, Ayse Ocak; Yazici, Omer Komi; Karaoglu, Aziz; Benekli, Mustafa; Buyukberber, Suleyman; Uysal, Mukremin

dc.contributor.author	Demirci, Umut
dc.contributor.author	Oflazoglu, Utku
dc.contributor.author	Kodaz, Hilmi
dc.contributor.author	Ciltas, Aydin
dc.contributor.author	Kefeli, Umut
dc.contributor.author	Akyol, Murat
dc.contributor.author	Ozturk, Banu
dc.contributor.author	Geredell, Caglayan
dc.contributor.author	Seker, Mehmet Metin
dc.contributor.author	Clhan, Saner
dc.contributor.author	Tastekin, Dldem
dc.contributor.author	Sevinc, Alper
dc.contributor.author	Akinci, Muhammad Bulent
dc.contributor.author	Taskoylu, Burcu Yapar
dc.contributor.author	Duran, Ayse Ocak
dc.contributor.author	Yazici, Omer Komi
dc.contributor.author	Karaoglu, Aziz
dc.contributor.author	Benekli, Mustafa
dc.contributor.author	Buyukberber, Suleyman
dc.contributor.author	Uysal, Mukremin
dc.date.accessioned	2021-03-05T14:52:31Z
dc.date.available	2021-03-05T14:52:31Z
dc.identifier.citation	Demirci U., Oflazoglu U., Kodaz H., Ciltas A., Kefeli U., Akyol M., Ozturk B., Geredell C., Seker M. M. , Clhan S., et al., "Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology", 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32
dc.identifier.other	av_b943632d-8f96-40be-80e8-b5640abc8970
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/123270
dc.identifier.uri	https://doi.org/10.1200/jco.2014.32.15_suppl.e16094
dc.language.iso	eng
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.title	Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	32
dc.contributor.firstauthorID	144178

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster